News

BioNTech and Pfizer to initiate first COVID-19-related clinical trial in Germany

BioNTech and Pfizer are jointly developing BNT162. The trial is the first clinical trial of a COVID-19 vaccine candidate to start in Germany, and is part of a global development program.

Read More

Apr 24, 2020

By : Team ABLE

Bugworks raises $7.5 millionfrom a Global Investment Syndicate to fight against Deadly Bacterial Superbugs

Bugworkshas raised $7.5 million from a Global Investment Syndicate to combat the global challenge posed by deadly bacterial superbugs.

Read More

Apr 23, 2020

By : Team ABLE

Agharkar Research Institute scientists develop microreactor for uniform size-nanoparticles

Scientists from Agharkar Research Institute have developed a microreactor that can produce large quantities of uniform size nanoparticles serving a major requirement in biomedical technology.

Read More

Apr 23, 2020

By : Team ABLE

DST supported NGO network tackle COVID-19 at community level through S&T interventions

Apart from preventing COVID-19 infection, these interventions have also provided an alternate source of livelihoods for women SHGs.

Read More

Apr 23, 2020

By : Team ABLE

CSIR to take sepsis drug to clinical trials for Covid-19 treatment

The Council of Scientific and Industrial Research (CSIR) is initiating a clinical trial to evaluate the efficacy of a drug.

Read More

Apr 22, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights